Woodline Partners’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-306,946
| Closed | -$253K | – | 993 |
|
2025
Q1 | $253K | Sell |
306,946
-2,651
| -0.9% | -$2.19K | ﹤0.01% | 868 |
|
2024
Q4 | $294K | Hold |
309,597
| – | – | ﹤0.01% | 889 |
|
2024
Q3 | $310K | Buy |
+309,597
| New | +$310K | ﹤0.01% | 554 |
|
2023
Q4 | – | Sell |
-173,877
| Closed | -$226K | – | 569 |
|
2023
Q3 | $226K | Hold |
173,877
| – | – | ﹤0.01% | 545 |
|
2023
Q2 | $299K | Hold |
173,877
| – | – | ﹤0.01% | 572 |
|
2023
Q1 | $254K | Buy |
173,877
+94,742
| +120% | +$138K | ﹤0.01% | 576 |
|
2022
Q4 | $128K | Sell |
79,135
-8,799
| -10% | -$14.3K | ﹤0.01% | 703 |
|
2022
Q3 | $295K | Sell |
87,934
-251,439
| -74% | -$844K | ﹤0.01% | 619 |
|
2022
Q2 | $1.24M | Buy |
339,373
+148,342
| +78% | +$540K | 0.02% | 493 |
|
2022
Q1 | $1.38M | Sell |
191,031
-118,566
| -38% | -$857K | 0.02% | 444 |
|
2021
Q4 | $4.21M | Sell |
309,597
-191,031
| -38% | -$2.6M | 0.06% | 307 |
|
2021
Q3 | $10.5M | Hold |
500,628
| – | – | 0.17% | 155 |
|
2021
Q2 | $12M | Buy |
500,628
+312,543
| +166% | +$7.49M | 0.22% | 115 |
|
2021
Q1 | $5.51M | Sell |
188,085
-33,402
| -15% | -$978K | 0.12% | 181 |
|
2020
Q4 | $6.62M | Buy |
+221,487
| New | +$6.62M | 0.18% | 143 |
|